Medicine
Voquezna Dual Pak kit
Voquezna Dual Pak kit is a prescription medicine containing Amoxicillin and Vonoprazan, marketed by Phathom Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store between 20°C and 25°C (68°F and 77°F). Brief exposure to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Amoxicillin and Vonoprazan
- Brand
- Voquezna Dual Pak
- Dosage form
- Kit
- Packs
- 14 blister pack
- Marketing authorisation holder
- Phathom Pharmaceuticals
- Manufacturer
- Phathom Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store between 20°C and 25°C (68°F and 77°F). Brief exposure to 15°C to 30°C (59°F to 86°F) permitted. Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.10Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 November 2023
- Identifiers
- RxCUI 197517, 308191, 2604800 +4DailyMed set ID 0cb2ee04-8581-46c8-a781-7be170ab5c86NDC 81520-250Application NDA215153
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 14 blister pack in 1 carton / 1 kit in 1 blister pack | 81520-250-14 | Phathom Pharmaceuticals | 8 November 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 May 2022 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Amoxicillin and Vonoprazan is a fixed-dose combination medicine indicated for the treatment of Helicobacter pylori (H. pylori) infection in adults, among other approved uses. It is available as kits. MedsAcross supplies Amoxicillin and Vonoprazan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Amoxicillin and VonoprazanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VOQUEZNA DUAL PAK prescribing information (Phathom Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Voquezna Dual Pak kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.